What is the HACEK (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella) group?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The HACEK group is a collection of slow-growing, gram-negative bacteria that are known to cause infective endocarditis, and the most effective treatment is ceftriaxone (2g IV daily for 4 weeks) for native valve endocarditis, as recommended by the American Heart Association 1.

Definition of HACEK Group

The HACEK group is an acronym that stands for Haemophilus species (H. parainfluenzae, H. aphrophilus, H. paraphrophilus), Aggregatibacter species (formerly Actinobacillus actinomycetemcomitans), Cardiobacterium hominis, Eikenella corrodens, and Kingella species.

Clinical Significance

These organisms are part of the normal oral flora and can enter the bloodstream during dental procedures or with poor oral hygiene. HACEK organisms are responsible for approximately 5-10% of all cases of community-acquired native valve endocarditis in patients who are not intravenous drug users, as stated in the guidelines by the American Heart Association 1.

Treatment

Treatment typically involves ceftriaxone, which is the preferred therapy due to its effectiveness against HACEK microorganisms, as shown in the guidelines 1. The duration of therapy for native valve endocarditis is 4 weeks, and for prosthetic valve endocarditis, the duration is 6 weeks.

Key Points

  • The HACEK group is a collection of slow-growing, gram-negative bacteria that cause infective endocarditis.
  • Ceftriaxone is the preferred treatment for HACEK endocarditis.
  • Treatment duration is 4 weeks for native valve endocarditis and 6 weeks for prosthetic valve endocarditis.
  • HACEK organisms are often difficult to culture, requiring extended incubation periods of up to 2-3 weeks for growth, as mentioned in the study 1.

From the Research

Definition of HACEK Group

  • The HACEK group refers to a collection of Gram-negative bacteria, including Haemophilus spp., Aggregatibacter actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae 2, 3.
  • These bacteria are part of the normal microbiota of the oral and upper respiratory tract in humans 3.

Characteristics of HACEK Organisms

  • HACEK organisms are fastidious, meaning they are difficult to culture and require specific conditions to grow 3, 4.
  • They are responsible for 1-3% of all infective endocarditis cases, with a favorable prognosis if properly identified and treated 2, 3.
  • The most common presenting symptoms of HACEK endocarditis include fever, splenomegaly, new or changing murmur, and microvascular phenomena 5.

Diagnosis and Treatment of HACEK Endocarditis

  • Diagnosis of HACEK endocarditis can be made using blood cultures, which may take several days to become positive 5.
  • Treatment typically involves third-generation cephalosporins, such as ceftriaxone, or fluoroquinolones, with a favorable outcome in 80-90% of cases 2, 3.
  • Surgical intervention may be necessary in some cases, particularly for patients with prosthetic valves or severe valve damage 2, 6.

Epidemiology and Prognosis of HACEK Endocarditis

  • The incidence of HACEK endocarditis is estimated to be around 0.14 per 100,000 person-years 5.
  • The overall survival rate for patients with HACEK endocarditis is around 87%, with a low mortality rate of 2% 5, 6.
  • HACEK endocarditis is often associated with underlying heart disease or prosthetic valves, and can have a significant impact on patient outcomes if left untreated or misdiagnosed 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

HACEK endocarditis: a review.

Expert review of anti-infective therapy, 2016

Research

HACEK endocarditis: state-of-the-art.

Expert review of anti-infective therapy, 2016

Research

Infective endocarditis caused by HACEK microorganisms.

Annual review of medicine, 1997

Research

Gram-negative endocarditis: disease presentation, diagnosis and treatment.

Current opinion in infectious diseases, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.